Ai-biopharma

Ai-biopharma is a Biopharma startup based in France that focuses on artificial intelligence-powered drug discovery, with a particular emphasis on antiviral, HBV functional cure, and CoV-related medications. The company specializes in medicinal chemistry research for preclinical drug candidates, harnessing in-silico solutions such as Chemoinformatics, Molecular Modeling, Docking, Data analysis, and SAR formatting/interpretation. Additionally, Ai-biopharma boasts an Artificial Intelligence platform that accelerates drug design, aiding in the selection of new preclinical candidate drugs. The startup operates in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Despite not having publicly disclosed the date of its last investment or the involved investors, Ai-biopharma has the potential to revolutionize the drug discovery process with its advanced technological approach. As AI continues to reshape various industries, Ai-biopharma's innovative methods could pave the way for groundbreaking developments in the pharmaceutical sphere, making it a compelling prospect for investment.